10-K Filing

HealthLynked Corp CIK: 1680139 FY 2017

Filing Information

Form Type	10-K
Accession Number	`0001213900-18-003844`
Period End Date	20171231
Filing Date	20180402
Fiscal Year	2017
Fiscal Period	FY
XBRL Instance	hlyk-20171231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 69 Income Statement 40 Cash Flow Statement 70 Stockholders Equity 23

Balance Sheet 69 line items

Line Item	Tag	Value	Unit	Period
Property, plant and equipment, net of accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$704.78K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$728.39K	USD	Point-in-time
Original issue discount and debt discount	`DebtInstrumentUnamortizedDiscount`	$26.88K	USD	Point-in-time
Original issue discount and debt discount	`DebtInstrumentUnamortizedDiscount`	-	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount	`DebtInstrumentUnamortizedDiscountCurrent`	$266.64K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$50.01K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$29.78K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$58.72K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount	`DebtInstrumentUnamortizedDiscountCurrent`	$114.33K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$113.35K	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$146.87K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	230.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$81.89K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	230.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	230.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$43.55K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	65.75M	shares	Point-in-time
Deferred offering costs	`DeferredOfferingCosts`	$121.62K	USD	Point-in-time
Deferred offering costs	`DeferredOfferingCosts`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	72.30M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$249.13K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	72.30M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$366.87K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	65.75M	shares	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $728,391 and $704,785 as of December 31, 2017 and 2016, respectively	`PropertyPlantAndEquipmentNet`	$63.38K	USD	Point-in-time
Common stock issuable, par value	`CommonStockIssuableIssuePrice`	$0.00	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $728,391 and $704,785 as of December 31, 2017 and 2016, respectively	`PropertyPlantAndEquipmentNet`	$70.84K	USD	Point-in-time
Common stock issuable, par value	`CommonStockIssuableIssuePrice`	$0.00	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$9.54K	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	80,643.00	shares	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	122,101.00	shares	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$9.54K	USD	Point-in-time
Total Assets	`Assets`	$439.78K	USD	Point-in-time
Total Assets	`Assets`	$329.51K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$148.47K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$253.51K	USD	Point-in-time
Capital lease, current portion	`CapitalLeaseObligationsCurrent`	$18.35K	USD	Point-in-time
Capital lease, current portion	`CapitalLeaseObligationsCurrent`	$18.35K	USD	Point-in-time
Due to related party, current portion	`DueToRelatedPartiesCurrent`	$917.39K	USD	Point-in-time
Due to related party, current portion	`DueToRelatedPartiesCurrent`	$311.79K	USD	Point-in-time
Notes payable, net of original issue discount and debt discount of $26,881 and $-0- as of December 31, 2017 and 2016, respectively	`NotesPayableCurrent`	-	USD	Point-in-time
Notes payable, net of original issue discount and debt discount of $26,881 and $-0- as of December 31, 2017 and 2016, respectively	`NotesPayableCurrent`	$70.19K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $266,642 and $114,332 as of December 31, 2017 and 2016, respectively	`ConvertibleDebtCurrent`	$485.67K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $266,642 and $114,332 as of December 31, 2017 and 2016, respectively	`ConvertibleDebtCurrent`	$811.86K	USD	Point-in-time
Derivative financial instruments	`DerivativeInstrumentsAndHedgesLiabilities`	$398.49K	USD	Point-in-time
Derivative financial instruments	`DerivativeInstrumentsAndHedgesLiabilities`	-	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$964.28K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$2.47M	USD	Point-in-time
Capital leases, long-term portion	`CapitalLeaseObligationsNoncurrent`	$39.75K	USD	Point-in-time
Capital leases, long-term portion	`CapitalLeaseObligationsNoncurrent`	$21.41K	USD	Point-in-time
Due to related party, long-term portion	`DueToRelatedPartiesNoncurrent`	$237.16K	USD	Point-in-time
Due to related party, long-term portion	`DueToRelatedPartiesNoncurrent`	-	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.24M	USD	Point-in-time
Total Liabilities	`Liabilities`	$2.49M	USD	Point-in-time
Common stock, par value $0.0001 per share, 230,000,000 shares authorized, 72,302,937 and 65,753,640 shares issued and outstanding as of December 31, 2017 and 2016, respectively	`CommonStockValue`	$6.58K	USD	Point-in-time
Common stock, par value $0.0001 per share, 230,000,000 shares authorized, 72,302,937 and 65,753,640 shares issued and outstanding as of December 31, 2017 and 2016, respectively	`CommonStockValue`	$7.23K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 122,101 and 80,643 shares as of December 31, 2017 and 2016, respectively	`CommonStockIssuableValue`	$6.45K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 122,101 and 80,643 shares as of December 31, 2017 and 2016, respectively	`CommonStockIssuableValue`	$8.28K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.64M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.20M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.71M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.12M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-2.05M	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-911.68K	USD	Point-in-time
Total Shareholders' Deficit	`StockholdersEquity`	$-296.27K	USD	Point-in-time
Total Liabilities and Shareholders' Deficit	`LiabilitiesAndStockholdersEquity`	$329.51K	USD	Point-in-time
Total Liabilities and Shareholders' Deficit	`LiabilitiesAndStockholdersEquity`	$439.78K	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Patient service revenue, net	`HealthCareOrganizationPatientServiceRevenue`	$1.95M	USD	Annual
Patient service revenue, net	`HealthCareOrganizationPatientServiceRevenue`	$2.10M	USD	Annual
Salaries and benefits	`LaborAndRelatedExpense`	$1.56M	USD	Annual
Salaries and benefits	`LaborAndRelatedExpense`	$2.02M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$1.85M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$1.54M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$23.61K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$16.46K	USD	Annual
Total Operating Expenses	`OperatingExpenses`	$3.12M	USD	Annual
Total Operating Expenses	`OperatingExpenses`	$3.89M	USD	Annual
(Loss) income from operations	`OperatingIncomeLoss`	$-1.79M	USD	Annual
(Loss) income from operations	`OperatingIncomeLoss`	$-1.17M	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-290.58K	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Financing cost	`AmortizationOfFinancingCosts`	-	USD	Annual
Financing cost	`AmortizationOfFinancingCosts`	$72.96K	USD	Annual
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-208.63K	USD	Annual
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-330.44K	USD	Annual
Proceeds from settlement of lawsuit	`GainLossRelatedToLitigationSettlement`	-	USD	Annual
Proceeds from settlement of lawsuit	`GainLossRelatedToLitigationSettlement`	$43.24K	USD	Annual
Change in fair value of derivative financial instrument	`GainOnDerivativeInstrumentsPretax`	-	USD	Annual
Change in fair value of derivative financial instrument	`GainOnDerivativeInstrumentsPretax`	$3.97K	USD	Annual
Interest expense	`InterestExpense`	$36.63K	USD	Annual
Interest expense	`InterestExpense`	$99.67K	USD	Annual
Total other expenses	`NonoperatingIncomeExpense`	$-789.67K	USD	Annual
Total other expenses	`NonoperatingIncomeExpense`	$-202.02K	USD	Annual
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.38M	USD	Annual
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.58M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-2.58M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.38M	USD	Annual
Basic	`EarningsPerShareBasic`	$-0.02	USD	Annual
Basic	`EarningsPerShareBasic`	$-0.04	USD	Annual
Fully diluted	`EarningsPerShareDiluted`	$-0.02	USD	Annual
Fully diluted	`EarningsPerShareDiluted`	$-0.04	USD	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	60.03M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	69.56M	shares	Annual
Fully diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	69.56M	shares	Annual
Fully diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	60.03M	shares	Annual

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.58M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.38M	USD	Annual
Depreciation	`DepreciationAndAmortization`	$23.61K	USD	Annual
Depreciation	`DepreciationAndAmortization`	$16.46K	USD	Annual
Stock based compensation, including amortization of prepaid fees	`EmployeeBenefitsAndShareBasedCompensation`	$146.21K	USD	Annual
Stock based compensation, including amortization of prepaid fees	`EmployeeBenefitsAndShareBasedCompensation`	$106.74K	USD	Annual
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-208.63K	USD	Annual
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-330.44K	USD	Annual
Financing cost	`PaymentOfFinancingCost`	$75.00K	USD	Annual
Financing cost	`PaymentOfFinancingCost`	$72.96K	USD	Annual
Change in fair value of derivative financial instrument	`GainLossOnSaleOfDerivatives`	-	USD	Annual
Change in fair value of derivative financial instrument	`GainLossOnSaleOfDerivatives`	$3.97K	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-290.58K	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-153.25K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-33.52K	USD	Annual
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$38.35K	USD	Annual
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-3.04K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$105.04K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$3.21K	USD	Annual
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$14.27K	USD	Annual
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$41.17K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-756.34K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.62M	USD	Annual
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$12.61K	USD	Annual
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$16.15K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-12.61K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-16.15K	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$848.64K	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$374.00K	USD	Annual
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$429.50K	USD	Annual
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$475.00K	USD	Annual
Proceeds from related party loans	`ProceedsFromRelatedPartyDebt`	$338.47K	USD	Annual
Proceeds from related party loans	`ProceedsFromRelatedPartyDebt`	$201.50K	USD	Annual
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	$149.28K	USD	Annual
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	$11.19K	USD	Annual
Proceeds from issuance of notes payable	`ProceedsFromNotesPayable`	$148.51K	USD	Annual
Proceeds from issuance of notes payable	`ProceedsFromNotesPayable`	-	USD	Annual
Repayment of notes payable and bank loans	`RepaymentsOfBankDebt`	$84.98K	USD	Annual
Repayment of notes payable and bank loans	`RepaymentsOfBankDebt`	$108.87K	USD	Annual
Payments on capital leases	`RepaymentsOfDebtAndCapitalLeaseObligations`	$18.35K	USD	Annual
Payments on capital leases	`RepaymentsOfDebtAndCapitalLeaseObligations`	$18.35K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.63M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$797.89K	USD	Annual
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$28.94K	USD	Annual
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-8.71K	USD	Annual
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$50.01K	USD	Point-in-time
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$29.78K	USD	Point-in-time
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$58.72K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$50.01K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$29.78K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$58.72K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$3.81K	USD	Annual
Cash paid during the period for interest	`InterestPaidNet`	$1.00K	USD	Annual
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	Annual
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	Annual
Fair value of warrants issued to extend maturity date of convertible notes payable, recognized as discount against convertible notes payable	`FairValueOfWarrantsIssuedToExtendMaturityDateOfConvertibleNotesPayable`	$7.51K	USD	Annual
Fair value of warrants issued to extend maturity date of convertible notes payable, recognized as discount against convertible notes payable	`FairValueOfWarrantsIssuedToExtendMaturityDateOfConvertibleNotesPayable`	-	USD	Annual
Fair value of warrants issued pursuant to Amended Investment Agreement	`FairValueOfWarrantsIssuedPursuantToAmendedInvestmentAgreement`	-	USD	Annual
Fair value of warrants issued pursuant to Amended Investment Agreement	`FairValueOfWarrantsIssuedPursuantToAmendedInvestmentAgreement`	$153.62K	USD	Annual
Fair value of warrants, beneficial conversion feature and original issue discount allocated to proceeds of convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	$272.96K	USD	Annual
Fair value of warrants, beneficial conversion feature and original issue discount allocated to proceeds of convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	$66.19K	USD	Annual
Fair value of warrants allocated to proceeds of common stock	`FairValueOfWarrantsAllocatedToProceedsOfCommonStock`	$89.38K	USD	Annual
Fair value of warrants allocated to proceeds of common stock	`FairValueOfWarrantsAllocatedToProceedsOfCommonStock`	-	USD	Annual
Initial derivative liabilities, beneficial conversion features and original issue discounts allocated to proceeds of convertible notes payable	`InitialDerivativeLiabilitiesBeneficialConversionFeaturesAndOriginalIssueDiscounts`	-	USD	Annual
Initial derivative liabilities, beneficial conversion features and original issue discounts allocated to proceeds of convertible notes payable	`InitialDerivativeLiabilitiesBeneficialConversionFeaturesAndOriginalIssueDiscounts`	$329.50K	USD	Annual
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$45.00K	USD	Annual
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$6.45K	USD	Annual
Common stock issued for preferred stock conversion	`ConversionOfStockAmountIssued1`	-	USD	Annual
Common stock issued for preferred stock conversion	`ConversionOfStockAmountIssued1`	$295.00	USD	Annual

Stockholders Equity 23 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-2.05M	USD	Point-in-time
Balance	`StockholdersEquity`	$-911.68K	USD	Point-in-time
Balance	`StockholdersEquity`	$-296.27K	USD	Point-in-time
Balance, Shares	`SharesOutstanding`	-	shares	Point-in-time
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$374.00K	USD	Annual
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$759.26K	USD	Annual
Consultant fees payable with common shares	`StockIssuedDuringPeriodForConsultantFees`	$6.45K	USD	Annual
Consultant fees paid with common shares and warrants	`StockIssuedDuringPeriodConsultantFeesPaidCommonSharesAndWarrants`	$87.17K	USD	Annual
Fair value of warrants allocated to proceeds of common stock	`AdjustmentsToAdditionalPaindInCapitalCommonStock`	$89.38K	USD	Annual
Fair value of warrants and beneficial conversion feature allocated to proceeds of convertible notes payable	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$272.96K	USD	Annual
Fair value of warrants allocated to proceeds of convertible notes payable	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$73.70K	USD	Annual
Fair value of warrants issued pursuant to Amended Investment Agreement	`AdditionalPaidInCapitalWarrantsIssuedPursuantToAmendedInvestmentAgreement`	$153.62K	USD	Annual
Fair value of warrants issued to extend convertible notes payable	`AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments`	$290.58K	USD	Annual
Consultant fees payable with common shares and warrants	`StockToBeIssuedForConsultantFees`	$53.93K	USD	Annual
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$20.81K	USD	Annual
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$20.42K	USD	Annual
Conversion of preferred shares to common shares	`StockIssuedDuringPeriodValueConversionOfUnits`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-2.58M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.38M	USD	Annual
Balance	`StockholdersEquity`	$-2.05M	USD	Point-in-time
Balance	`StockholdersEquity`	$-911.68K	USD	Point-in-time
Balance	`StockholdersEquity`	$-296.27K	USD	Point-in-time
Balance, Shares	`SharesOutstanding`	-	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.